$6.92
0[0.00%]
At close: Apr 18
$6.92
0[0.00%]
After Hours: 4:00PM EDT
TScan Therapeutics
(NASDAQ:TCRX)Latest News for TScan Therapeutics Stock (NASDAQ:TCRX)
TScan Therapeutics Stock (NASDAQ: TCRX)
Categories: All
Wednesday, April 17, 2024
Tuesday, April 16, 2024
- TScan Therapeutics shares are trading lower after the company announced that it commenced a $125 million proposed public offering. The company provided an update on its solid tumor and heme malignancies clinical programs.Benzinga Newsdesk - 3 days ago
- TScan Therapeutics Reports Launch Of $125M Proposed Public OfferingBenzinga Newsdesk - 3 days ago
- TScan Therapeutics Provides Update On Its Solid Tumor And Heme Malignancies Clinical ProgramsBenzinga Newsdesk - 3 days ago
Friday, March 22, 2024
Thursday, March 07, 2024
Wednesday, March 06, 2024
Monday, February 26, 2024
Thursday, February 01, 2024
Monday, January 29, 2024
Thursday, January 18, 2024
Monday, December 11, 2023
Monday, December 04, 2023
Thursday, November 09, 2023
- Recap: TScan Therapeutics Q3 EarningsBenzinga Insights - Nov 9, 2023, 7:55AM
- TScan Therapeutics Ended Q3 With Cash, Cash Equivalents, And Marketable Securities Of $215.4M, Funding Operations Into 2026Benzinga Newsdesk - Nov 9, 2023, 7:28AM
- TScan Therapeutics Q3 EPS $(0.24) Beats $(0.45) Estimate, Sales $3.89M Miss $4.09M EstimateBenzinga Newsdesk - Nov 9, 2023, 7:28AM
Tuesday, November 07, 2023
Wednesday, October 25, 2023
Tuesday, August 29, 2023
Monday, August 14, 2023
Thursday, August 10, 2023
- TScan Therapeutics Ended 2Q 2023 With Cash And Cash Equivalents Of $208.8M, Which Along With $30M Proceeds From Amgen, Will Fund The Company Into 2026Benzinga Newsdesk - Aug 10, 2023, 7:26AM
- TScan Therapeutics Q2 EPS $(0.51) Up From $(0.63) YoY, Sales $3.15M Down From $4.06M YoYBenzinga Newsdesk - Aug 10, 2023, 7:25AM
Tuesday, July 25, 2023
- Chief Accounting Officer at TScan Therapeutics Acquires Company Stock Options Worth 25,000 SharesBenzinga Insights - Jul 25, 2023, 11:00AM
- TScan Therapeutics Has Appointed Gavin MacBeath As The Interim Principal Financial Officer, Effective July 21, 2023, Replacing Brian Silver, Who Had Previously Announced His Resignation As CFO; MacBeath Has Been Serving As CEO Since May 24, 2023 - 8KBenzinga Newsdesk - Jul 25, 2023, 7:20AM
Thursday, June 29, 2023
Thursday, June 22, 2023
Friday, June 16, 2023
- Chief Legal Officer at TScan Therapeutics Acquires Company Stock Options Worth 430,000 SharesBenzinga Insights - Jun 16, 2023, 11:03AM
- TScan Therapeutics Chief Executive Officer Awarded $3.02M Worth of Stock OptionsBenzinga Insights - Jun 16, 2023, 11:03AM
- Chief Financial Officer at TScan Therapeutics Acquires Company Stock Options Worth 632,500 SharesBenzinga Insights - Jun 16, 2023, 11:03AM
- TScan Therapeutics Director Awarded $98K Worth of Stock OptionsBenzinga Insights - Jun 16, 2023, 11:03AM
- TScan Therapeutics Board Member Awarded $94K Worth of Stock OptionsBenzinga Insights - Jun 16, 2023, 11:02AM
- Director at TScan Therapeutics Acquires Company Stock Options Worth 35,000 SharesBenzinga Insights - Jun 16, 2023, 11:02AM
- Chief Medical Officer at TScan Therapeutics Acquires Company Stock Options Worth 430,000 SharesBenzinga Insights - Jun 16, 2023, 11:02AM
- TScan Therapeutics Director Awarded $94K Worth of Stock OptionsBenzinga Insights - Jun 16, 2023, 11:01AM
Wednesday, June 07, 2023
Tuesday, June 06, 2023
Tuesday, May 30, 2023
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - May 30, 2023, 1:31PM
- Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - May 30, 2023, 1:27PM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - May 30, 2023, 9:07AM
- Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving PremarketLisa Levin - May 30, 2023, 8:12AM